EMAIL THIS PAGE TO A FRIEND

Nature communications

HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.


PMID 25818806

Abstract

Intracellular transport of cargos, including many viruses, involves directed movement on microtubules mediated by motor proteins. Although a number of viruses bind motors of opposing directionality, how they associate with and control these motors to accomplish directed movement remains poorly understood. Here we show that human immunodeficiency virus type 1 (HIV-1) associates with the kinesin-1 adaptor protein, Fasiculation and Elongation Factor zeta 1 (FEZ1). RNAi-mediated FEZ1 depletion blocks early infection, with virus particles exhibiting bi-directional motility but no net movement to the nucleus. Furthermore, both dynein and kinesin-1 motors are required for HIV-1 trafficking to the nucleus. Finally, the ability of exogenously expressed FEZ1 to promote early HIV-1 infection requires binding to kinesin-1. Our findings demonstrate that opposing motors both contribute to early HIV-1 movement and identify the kinesin-1 adaptor, FEZ1 as a capsid-associated host regulator of this process usurped by HIV-1 to accomplish net inward movement towards the nucleus.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

40725
1,3-Dimethyl-2-imidazolidinone, absolute, over molecular sieve (H2O ≤0.04%), ≥99.5% (GC)
C5H10N2O
40727
1,3-Dimethyl-2-imidazolidinone, ≥99.0% (GC)
C5H10N2O
193453
1,3-Dimethyl-2-imidazolidinone, reagent grade
C5H10N2O
GW23014 Anti-Actin, Cytoplasmic 1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1406861
Anti-FEZ1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
PRS4265
Anti-FEZ1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA038490
Anti-FEZ1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1411687
Anti-FEZ1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA006294
Anti-LZTS1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV39473
Anti-LZTS1 antibody produced in rabbit, IgG fraction of antiserum
HPA022046
Anti-LZTS1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106278
Anti-LZTS1 antibody produced in rabbit, affinity isolated antibody
SAB4500487
Anti-PARP (Cleaved-Asp214) antibody produced in rabbit, affinity isolated antibody
SAB4500488
Anti-PARP (Cleaved-Gly215) antibody produced in rabbit, affinity isolated antibody
P7605 Anti-PARP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
AV33754
Anti-PARP1 antibody produced in rabbit, IgG fraction of antiserum
HPA045168
Anti-PARP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
S5386
DL-Serine, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98% (HPLC)
C3H7NO3
S4375
DL-Serine, ≥98% (TLC)
C3H7NO3
P248 Monoclonal Anti-PARP antibody produced in mouse, clone C-2-10, ascites fluid
WH0000142M1
Monoclonal Anti-PARP1 antibody produced in mouse, clone 3G4, purified immunoglobulin, buffered aqueous solution
SAB1403527
Monoclonal Anti-PARP1, (N-terminal) antibody produced in mouse, clone 2C7, purified immunoglobulin, buffered aqueous solution
PLA0184
Rabbit anti-PARP1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
S0450000
Serine, European Pharmacopoeia (EP) Reference Standard
C3H7NO3